A critical review: serum cytokines and creatinine/cystatin C ratio as prognostic biomarkers in advanced cancer patients treated with anti-PD-1/PD-L1 therapy

Support Care Cancer. 2024 Jul 24;32(8):543. doi: 10.1007/s00520-024-08751-5.
No abstract available

Publication types

  • Review
  • Letter
  • Comment

MeSH terms

  • B7-H1 Antigen / blood
  • Biomarkers, Tumor / blood
  • Creatinine* / blood
  • Cystatin C* / blood
  • Cytokines* / blood
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use
  • Neoplasms* / blood
  • Neoplasms* / drug therapy
  • Prognosis
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors

Substances

  • Creatinine
  • Cystatin C
  • Cytokines
  • Immune Checkpoint Inhibitors
  • Biomarkers, Tumor
  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor
  • CD274 protein, human